News
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.
CEO Kurt Workman said the company recently made two FDA submissions for baby health monitoring products.
The acquisition expands the senior-focused company's offerings to include a workflow management program and value-based care reimbursement assistance.
Fire1, a remote patient monitoring company for heart failure patients, and Protai, an AI-powered drug discovery platform, scored funding.
Tyto Insights for Wheeze Detection analyzes lung sounds for possible wheezing in adults and children 2 and older.
The platform connects adults with conditions like autism, ADHD, OCD or Tourette's with care teams trained to help with their specific needs.
It will use the proceeds to continue scaling with the goal of reaching 25,000 doctors by 2024.
It features 24/7 nursing support via video call.
BlueRock Therapeutics will utilize Rune Labs' StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson's disease.
The tech giant also launched its Open Health Stack, a suite of open source tools that aim to help developers build digital health apps in low-resource settings.